Latest period
-$62.9M
YoY change
+4.6%
5Y CAGR
—
Peak year (FY2021)
-$9.94M
Latest annual
-$51.8M
Free Cash Flow history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: -$51.8M
Free Cash Flow growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: +4.6%
Free Cash Flow history table for Alto Neuroscience (ANRO) from 2021 to 2025
| FY2025 | -$51.8M | +4.6% | -$2.29M | ||
| FY2024 | -$49.5M | +45.9% | -$15.6M | ||
| FY2023 | -$33.9M | +60.6% | -$12.8M | ||
| FY2022 | -$21.1M | +112.5% | -$11.2M | ||
| FY2021 | -$9.94M | — | — |
- FY2025-$51.8M+4.6%
- FY2024-$49.5M+45.9%
- FY2023-$33.9M+60.6%
- FY2022-$21.1M+112.5%
- FY2021-$9.94M—
Free Cash Flow values are taken from Alto Neuroscience's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Alto Neuroscience (ANRO)
Free Cash Flow for Alto Neuroscience (ANRO): headline value -$62.9M · YoY +4.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Alto Neuroscience (ANRO) free cash flow totalled -$51.8M – edged up 4.6% year-over-year.
2021 marks the peak free cash flow at -$9.94M, with the historical low of -$51.8M recorded in 2025.
Alto Neuroscience Free Cash Flow by Year
Alto Neuroscience Free Cash Flow 2025: -$51.8M
2025's free cash flow for Alto Neuroscience came in at -$51.8M, edged up 4.6% from 2024. This figure represents the lowest annual value in the available history.
Alto Neuroscience Free Cash Flow 2024: -$49.5M
Alto Neuroscience posted free cash flow of -$49.5M in 2024, surged 45.9% from 2023.
Alto Neuroscience Free Cash Flow 2023: -$33.9M
In 2023, Alto Neuroscience reported free cash flow of -$33.9M, surged 60.6% from 2022.
Alto Neuroscience Free Cash Flow 2022: -$21.1M
Alto Neuroscience free cash flow in 2022 was -$21.1M, surged 112.5% from 2021.
Alto Neuroscience Free Cash Flow 2021: -$9.94M
Alto Neuroscience free cash flow in 2021 was -$9.94M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Free Cash Flow
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest free cash flow
| $19.7B | |
| $17.8B | |
| $16.1B | |
| $12.4B | |
| $8.97B | |
| $8.1B | |
| $6.29B | |
| $4.52B |
- $19.7B
- $17.8B
- $16.1B
- $12.4B
- $8.97B
- $8.1B
- $4.52B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.